Neptune Technologies & Bioresources Inc ROE 2009-2019 | NEPT

Current and historical return on equity (ROE) values for Neptune Technologies & Bioresources Inc (NEPT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Neptune Technologies & Bioresources Inc ROE for the three months ending March 31, 2019 was -19.34%.
Neptune Technologies & Bioresources Inc ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $-0.02B $0.05B -28.22%
2018-12-31 $0.00B $0.06B 0.00%
2018-09-30 $0.00B $0.07B 3.49%
2018-06-30 $0.00B $0.06B 3.77%
2016-11-30 $0.00B $0.05B 6.09%
2016-05-31 $-0.01B $0.05B -13.89%
2016-03-31 $-0.00B $0.05B -10.81%
2015-12-31 $-0.01B $0.05B -23.53%
2015-09-30 $-0.01B $0.05B -21.05%
2015-06-30 $-0.02B $0.06B -33.95%
2015-03-31 $-0.02B $0.07B -30.56%
2014-12-31 $-0.02B $0.07B -21.48%
2014-09-30 $-0.02B $0.08B -33.95%
2014-06-30 $-0.02B $0.09B -24.29%
2014-03-31 $-0.02B $0.06B -28.17%
2013-12-31 $-0.02B $0.05B -28.85%
2013-06-30 $-0.02B $0.05B -38.55%
2013-03-31 $-0.02B $0.06B -43.84%
2012-12-31 $-0.02B $0.06B -43.87%
2012-09-30 $-0.01B $0.03B -15.63%
2012-06-30 $-0.00B $0.03B -9.84%
2012-03-31 $-0.00B $0.03B -10.62%
2011-12-31 $-0.00B $0.03B -4.26%
2011-09-30 $0.00B $0.03B 5.06%
2011-06-30 $0.00B $0.02B 19.05%
2011-03-31 $0.00B $0.01B 32.65%
2010-12-31 $0.00B $0.02B 19.05%
2010-09-30 $0.00B $0.01B 23.53%
2010-06-30 $0.00B $0.01B 13.79%
2010-03-31 $0.00B $0.01B 0.00%
2009-12-31 $0.00B $0.01B 0.00%
2009-09-30 $-0.00B $0.01B -63.16%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.499B $0.018B
Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.348B 29.07
Medtronic (MDT) Ireland $135.189B 19.31
Stryker (SYK) United States $77.613B 27.70
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $42.395B 26.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.186B 0.00
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.565B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.282B 16.24
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $18.881B 0.00
ResMed (RMD) United States $17.703B 33.82
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.272B 0.00
Bio-Rad Laboratories (BIO) United States $9.392B 49.79
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.231B 526.83
Hill-Rom Holdings (HRC) United States $7.018B 21.28
Perrigo (PRGO) Ireland $7.012B 11.85
Aurora Cannabis (ACB) Canada $6.936B 68.40
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.251B 51.03
ICU Medical (ICUI) United States $5.188B 30.95
GW Pharmaceuticals (GWPH) United Kingdom $4.991B 0.00
Neogen (NEOG) United States $3.334B 54.21
NuVasive (NUVA) United States $3.016B 24.63
Hutchison China MediTech (HCM) China $2.777B 0.00
Agios Pharmaceuticals (AGIO) United States $2.746B 0.00
National Vision Holdings (EYE) United States $2.480B 52.83
Quidel (QDEL) United States $2.268B 23.54
Aphria (APHA) $1.604B 0.00
Cardiovascular Systems (CSII) United States $1.543B 886.40
Phibro Animal Health (PAHC) United States $1.216B 18.22
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.93
NanoString Technologies (NSTG) United States $1.114B 0.00
Lantheus Holdings (LNTH) United States $1.097B 29.13
PetIQ (PETQ) United States $1.015B 24.66
Quanterix (QTRX) United States $0.779B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.750B 21.04
Omeros (OMER) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.717B 0.00
TG Therapeutics (TGTX) United States $0.681B 0.00
LeMaitre Vascular (LMAT) United States $0.598B 28.97
OraSure Technologies (OSUR) United States $0.530B 24.40
Surmodics (SRDX) United States $0.527B 76.59
Meridian Bioscience (VIVO) United States $0.492B 15.04
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.321B 22.20
Vapotherm (VAPO) United States $0.320B 0.00
Zynex (ZYXI) United States $0.251B 25.77
Cytosorbents (CTSO) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.092B 20.16
InfuSystems Holdings (INFU) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 18.33
MRI INTERVENTNS (MRIC) United States $0.052B 0.00